You are a current customer or distributor of IB10?

You want to learn more about IB10?


The information provided in this quote request will be forwarded to the distributors responsible for your area. No in vitro diagnostic (IVD) product based on the Nexus IB10 technology is available for distribution in, or delivery to, the United States of America or Canada.  Further, no IVD product based on the Nexus IB10 technology is approved for use in the United States of America or Canada.

You are a current customer or distributor of IB10? You want to learn more about IB10?
The information provided in this quote request will be forwarded to the distributors responsible for your area. No in vitro diagnostic (IVD) product based on the Nexus IB10 technology is available for distribution in, or delivery to, the United States of America or Canada.  Further, no IVD product based on the Nexus IB10 technology is approved for use in the United States of America or Canada.
You are a current customer or distributor of IB10? You want to learn more about IB10?
The information provided in this quote request will be forwarded to the distributors responsible for your area. No in vitro diagnostic (IVD) product based on the Nexus IB10 technology is available for distribution in, or delivery to, the United States of America or Canada.  Further, no IVD product based on the Nexus IB10 technology is approved for use in the United States of America or Canada.

SPHINGOTEC GROUP


COMBINING INNOVATIVE BIOMARKER WITH OUTSTANDING TECHNOLOGY


LATEST NEWS



Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression. sphingotec launches first IVD test for DPP3 on Nexus IB10 Point-of-Care platform



Learn more

Sphingotec reveals novel results on bioactive adrenomedullin for diagnosis and therapy monitoring of septic shock at the 39th International Symposium on Intensive Care and Emergency Medicine (ISICEM)



Learn more

Sphingotec announces new data on the kidney function marker proenkephalin (penKid®) presented at 24th International Conference on Advances in Critical Care Nephrology



Learn more

Endothelial disruption: Rapid translation from bench to bedside





Learn more